Rhonda Farnum - 21 Apr 2025 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Signature
/s/ Brett A. Grimaud, Attorney-in-Fact
Issuer symbol
TBPH
Transactions as of
21 Apr 2025
Net transactions value
-$36,000
Form type
4
Filing time
23 Apr 2025, 18:00:35 UTC
Previous filing
04 Mar 2025
Next filing
22 May 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TBPH Ordinary Shares Sale $36,000 -4,000 -1.1% $9.00 370,038 21 Apr 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Remarks:

This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 03/14/2024.